Finance

Lists
SLXN:NASDAQ
Silexion Therapeutics Corp
$0.41
+18.51%
(+0.065) 1D
Sep 10, 11:38:05 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLXN...
Open
$0.42
High
$0.49
Low
$0.39
Mkt. cap
2.38M
Avg. vol.
484.69K
Volume
102.65M
52-wk high
$77.70
52-wk low
$0.34
EPS
-$56.45
Beta
-0.35
Shares outstanding
5.76M
No. of employees
14
Open
$0.42
High
$0.49
Low
$0.39
Mkt. cap
2.38M
Avg. vol.
484.69K
Volume
102.65M
52-wk high
$77.70
52-wk low
$0.34
EPS
-$56.45
Beta
-0.35
Shares outstanding
5.76M
No. of employees
14
News stories
From web sources and news partners
About Silexion Therapeutics Corp
CEO-
Employees14
Founded2008
Headquarters-
SectorBiotechnology
Websitesilexion.com
Analyst ratings
Based on 1 analyst giving stock ratings to SLXN in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SLXN in the last 3 months
Highest
Current $0.41
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Hold
Maintained
-
-
08/19/2026
Theodore O'Neill
Litchfield Hills
Buy
Initiated
$6.00
+1,348.6%
12/15/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.16M
3.38M
1.37M
2.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14M
1.03M
1.38M
1.47M
Operating expense
3.29M
4.41M
2.75M
3.68M
Total operating expenses
3.29M
4.41M
2.75M
3.68M
Operating income
-3.29M
-4.41M
-2.75M
-3.68M
Other non operating income
23.00K
-35.00K
11.00K
155.00K
EBT including unusual items
-3.26M
-4.41M
-2.73M
-3.55M
EBT excluding unusual items
-3.26M
-4.41M
-2.73M
-3.55M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.26M
-4.41M
-2.73M
-3.55M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
39.00K
69.00K
32.00K
14.00K
Interest expense
-
-
-
-
Net interest expenses
39.00K
69.00K
32.00K
14.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.29M
-4.40M
-2.75M
-3.68M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps